Sepsis Diagnostics Market by Technology, Product, Method, Usability, Pathogen - Global Forecast to 2021

News provided by

Sep 28, 2016, 06:37 ET

NEW YORK, Sept. 28, 2016 /PRNewswire/ -- The sepsis diagnostics market is expected to reach USD 564.1 million by 2021, at a CAGR of 8.8% from 2016 to 2021.

The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis in the neonate and adult population across the globe. In addition, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing number of product approvals are supporting the growth of this market. On the other hand, lack of standard protocols and awareness as well as shortage of skilled staff are the major challenges in this market.

In this report, the sepsis diagnostics market has been segmented on the basis of product (instruments, blood culture media, assay kits & reagents, and software), technology (microbiology, molecular diagnostics, immunoassays, and flow cytometry), usability (laboratory testing & point-of-care testing), method (conventional diagnostics and automated diagnostics), pathogen (bacterial sepsis, fungal sepsis, and others) and region (North America, Europe, APAC, and RoW). On the basis of products, the blood culture media segment is estimated to account for the largest share of the sepsis diagnostics market in 2016. High use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis is driving the growth of this segment across the globe.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the sepsis diagnostics market in 2016, followed by Europe. A number of factors such as the high prevalence of sepsis, increasing number of invasive procedures, growing adoption of high-end sepsis diagnostics devices, and rising government support are contributing to the growth of the North American sepsis diagnostics market. However, lack of standard protocol for sepsis diagnostics and high cost of diagnostic devices are limiting the growth of sepsis diagnostics market in the North America.

The sepsis diagnostics market consists of a large number of big, medium, and small-sized companies. As of 2015, the sepsis diagnostics market was dominated by bioMérieux SA (France), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Cepheid Inc. (U.S.). New product launches and product approvals; partnerships, agreements, and collaborations; and acquisitions; were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the sepsis diagnostics market.

OBJECTIVES OF THE STUDY
To define, describe, and forecast the global sepsis diagnostics market on the basis of technology, products, method, usability, pathogen, and region
To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To provide a five-year forecast for various segments of the sepsis diagnostics market, in terms of revenue, with respect to four main regions, namely, North America (the U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (India, China, Japan, and the Rest of Asia-Pacific), and the Rest of the World
To strategically profile the key players and comprehensively analyze their market shares and core competencies2
To track and analyze competitive developments such as new product launches,; agreements and partnerships,; and mergers and acquisitions in the global sepsis diagnostics market

1. Micromarkets are defined as the further segments and subsegments of the global sepsis diagnostics market included in the report.
2. Core competencies of the companies are captured in terms of their key developments and key strategies adopted to maintain their market positions.

Target Audience:
Sepsis diagnostic device manufacturing companies
Clinical laboratories
Hospitals and clinics
Research institutes and clinical research organizations (CROs)
Market research and consulting firms
Sepsis diagnostic devices suppliers and distributors
Blood culture media manufacturers
Blood culture media distributors and suppliers

Scope of the Report
This research report categorizes the sepsis diagnostics market into the following segments:
Global Sepsis Diagnostics Market, by Technology
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry

Global Sepsis Diagnostics Market, by Product
Blood Culture Media
Instruments
Assays & Reagents
Software

Global Sepsis Diagnostics Market, by Method
Conventional Diagnostics
Automated Diagnostics

Global Sepsis Diagnostics Market, by Usability
Laboratory Testing
Point-of-care Testing

Global Sepsis Diagnostics Market, by Pathogen
Bacterial Sepsis
Gram-negative Bacterial Sepsis
Gram-positive Bacterial Sepsis
Fungal Sepsis
Others

Global Sepsis Diagnostics Market, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Rest of the World

Read the full report: http://www.reportlinker.com/p04169035-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com